The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 21.25 is strong.
Procter & Gamble Hygiene and Health Care has a Altman Z-Score of 21.25, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
Procter & Gamble Hygiene and Health Care (BOM:500459) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care Altman Z-Score Chart
Procter & Gamble Hygiene and Health Care Annual Data
BOM:500459 vs PG, CL, KVUE: Altman Z-Score Comparison
For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Hygiene and Health Care Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Hygiene and Health Care's Altman Z-Score falls into.
Procter & Gamble Hygiene and Health Care Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Altman Z-Score of 21.25 as of Jul. 13, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. This is 34% below median its historical median of 32.21. Over the past decade, Procter & Gamble Hygiene and Health Care's Altman Z-Score has ranged from 21.25 to 34.86. According to the industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #58 out of 1932 companies in the Consumer Packaged Goods industry, placing it in the top 3%.
Is Procter & Gamble Hygiene and Health Care's Altman Z-Score too high?
Procter & Gamble Hygiene and Health Care's current Altman Z-Score of 21.25 is 34% below median its 10-year median of 32.21. Over the past 10 years, this metric has ranged from a low of 21.25 to a high of 34.86. The Consumer Packaged Goods industry median Altman Z-Score is 2.85. Procter & Gamble Hygiene and Health Care's value of 21.25 is 645.6% above this industry median. Based on the distribution chart, Procter & Gamble Hygiene and Health Care ranks #58 out of 1932 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Altman Z-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #58 out of 1932 companies for Altman Z-Score. This places Procter & Gamble Hygiene and Health Care in the top 3% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.85. Procter & Gamble Hygiene and Health Care's value of 21.25 is 645.6% above this benchmark. Historically, Procter & Gamble Hygiene and Health Care's own Altman Z-Score has ranged from 21.25 to 34.86 over the past decade. While the company's 10-year median is 32.21 vs. the industry median of 2.85, Procter & Gamble Hygiene and Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.85, based on 1,932 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Hygiene and Health Care's current Altman Z-Score of 21.25 is 645.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Hygiene and Health Care's current Altman Z-Score is 21.25, which is 34% below median its own 10-year median of 32.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹16,016.99, compared to a current price of ₹8,938.30 — trading 44.2% below its estimated fair value. The current Altman Z-Score is 21.25, which is 34% below median its 10-year median of 32.21 and 645.6% above the Consumer Packaged Goods industry median of 2.85. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Altman Z-Score is 21.25 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued.
The current stock price of ₹8,938.30 is trading 44.2% below its estimated GF Value™ of ₹16,016.99.
GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.
Key valuation signals for BOM:500459:
Altman Z-Score: 21.25 (34% below median its 10-year median of 32.21)
GF Value™: ₹16,016.99 vs. price of ₹8,938.30 (44.2% below fair value)
Industry Position: 645.6% above the Consumer Packaged Goods median (#58 of 1932)
No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Hygiene and Health Care Business Description
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
83GF Score
Get the complete analysis for BOM:500459
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500459 has been successfully added to your 
